A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy
Clinical trial NCT06602739 · COMPLETED
Trial details
- NCT number
- NCT06602739
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-19
- Primary completion
- 2025-04-23
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.